greeksoup/ stock research

Benchmark Electronics Inc.: Q1 FY2026 earnings call

What management said about Q1 FY2026, from the documents filed with the SEC on 29 April 2026: press release. Guidance figures: 1 raised, 5 new. The quarter’s numbers.

Key takeaways

  • Revenue rose from a year earlier: Revenue was $677 million, up from $632 million in the first quarter of 2025 and down from $704 million in the fourth quarter of 2025. Source
  • Diluted EPS rose to $0.36: Diluted GAAP EPS was $0.36, against $0.10 a year earlier and $0.17 in the fourth quarter; non-GAAP diluted EPS was $0.58, against $0.52 a year earlier. Source
  • Semi-Cap up sequentially, down yearly: Semi-Cap revenue was $191 million, 28% of the total, up from $171 million in the fourth quarter and down from $195 million in the first quarter of 2025. Source
  • AC&C and Medical up from a year earlier: AC&C revenue was $105 million against $74 million a year earlier; Medical was $128 million against $104 million. Both were below fourth-quarter levels of $108 million and $144 million. Source
  • GAAP operating margin rose to 3.2%: GAAP operating margin was 3.2%, against 1.9% a year earlier and 2.9% in the fourth quarter; non-GAAP operating margin was 4.8%, against 4.6% a year earlier. Source
  • Free cash flow was $28.8 million: Free cash flow was $28.8 million, against $27.3 million a year earlier and $48.1 million in the fourth quarter of 2025. Source

“Our first quarter results have increased our confidence in 2026 and are a clear sign of the benefits from the customer ‑ first initiatives we began implementing over two years ago and continue to build on today,”

David Moezidis, Benchmark’s President and CEO

Guidance

AreaPeriodFigureAgainst last quarter
Full year revenue growth SourceFull year 20269-10%Raised from mid-single-digit growth
Revenue SourceSecond quarter 2026$700 million to $740 millionNew
Diluted GAAP EPS SourceSecond quarter 2026$0.51 to $0.57New
Diluted non-GAAP EPS SourceSecond quarter 2026$0.65 to $0.71New
Stock-based compensation expense (excluded from non-GAAP EPS) SourceSecond quarter 2026approximately $6.1 millionNew
Other non-operating expenses (excluded from non-GAAP EPS) SourceSecond quarter 2026$0.8 million to $1.2 millionNew

What changed from last quarter

  • Guidance raised: Full year 2026 revenue growth expectation raised to 9-10% from prior mid-single-digit growth expectations. Source
  • New guidance: Second quarter 2026 ranges given for revenue, GAAP and non-GAAP EPS, stock-based compensation and non-operating expenses. Source
  • New: Jeff Benck stepped out of the CEO role at the end of the fourth quarter of 2025; David Moezidis is named President and CEO.

Results and profit

  • Revenue rose from a year earlier: Revenue was $677 million, up from $632 million in the first quarter of 2025 and down from $704 million in the fourth quarter of 2025. Source
  • Diluted EPS rose to $0.36: Diluted GAAP EPS was $0.36, against $0.10 a year earlier and $0.17 in the fourth quarter; non-GAAP diluted EPS was $0.58, against $0.52 a year earlier. Source
  • Net income rose to $13.0 million: Net income was $13.0 million, against $3.6 million in the first quarter of 2025. Source
  • Operating income rose to $21.9 million: Income from operations was $21.9 million, against $11.8 million a year earlier. Source
  • Tax expense rose with pretax income: Income tax expense was $5.4 million on pretax income of $18.4 million, against $4.8 million on $8.4 million a year earlier. Source

Segments and end markets

  • Semi-Cap up sequentially, down yearly: Semi-Cap revenue was $191 million, 28% of the total, up from $171 million in the fourth quarter and down from $195 million in the first quarter of 2025. Source
  • AC&C and Medical up from a year earlier: AC&C revenue was $105 million against $74 million a year earlier; Medical was $128 million against $104 million. Both were below fourth-quarter levels of $108 million and $144 million. Source
  • Industrial and A&D lower sequentially: Industrial revenue was $133 million, down from $144 million in the fourth quarter; A&D was $120 million, down from $137 million. Source

“We are seeing improvement across a broad cross ‑ section of our business, led by strengthening in Semi ‑ Cap and continued momentum in AC&C and Medical.”

David Moezidis, Benchmark’s President and CEO

Costs and margins

  • Gross margin near 10 percent: GAAP gross margin was 10.2%, against 10.0% a year earlier and 10.5% in the fourth quarter; non-GAAP gross margin was 10.3%, against 10.1% a year earlier. Source
  • GAAP operating margin rose to 3.2%: GAAP operating margin was 3.2%, against 1.9% a year earlier and 2.9% in the fourth quarter; non-GAAP operating margin was 4.8%, against 4.6% a year earlier. Source
  • Restructuring and settlement costs fell: Restructuring charges and other costs were $3.7 million, against $11.4 million a year earlier; the legal and other settlement loss was $154 thousand, against $10.3 million. Source
  • Interest income down, other expense up: Interest income was $1.9 million, against $2.7 million a year earlier; other expense, net was $1.7 million, against $0.8 million. Source
  • Stock-based compensation rose: Stock-based compensation expense was $5.4 million, against $4.4 million in the first quarter of 2025. Source

Working capital and inventory

  • Cash conversion cycle held at 67 days: Days in cash conversion cycle were 67, against 86 in the first quarter of 2025 and 67 in the fourth quarter of 2025. Source
  • Inventory days fell year over year: Days in inventory were 75, against 89 a year earlier and 69 in the fourth quarter. Inventories were $507.4 million at March 31, 2026, against $482.5 million at December 31, 2025. Source
  • Payables rose to $451.1 million: Accounts payable were $451.1 million at March 31, 2026, against $403.2 million at December 31, 2025; days in accounts payable were 67. Source
  • Receivables fell to $375.9 million: Accounts receivable, net were $375.9 million, against $391.1 million at December 31, 2025; days in accounts receivable were 50, against 53 a year earlier. Source

“This positions us for sequential and year ‑ over ‑ year growth through the remainder of the year, with full year revenue now expected to be in the 9 - 10% range”

David Moezidis, Benchmark’s President and CEO

Cash flow and capital returns

  • Operating cash flow was $47.0 million: Net cash provided by operating activities was $47.0 million, against $31.5 million in the first quarter of 2025. Source
  • Free cash flow was $28.8 million: Free cash flow was $28.8 million, against $27.3 million a year earlier and $48.1 million in the fourth quarter of 2025. Source
  • Capital spending rose to $18.3 million: Additions to property, plant and equipment and software were $18.3 million, against $4.2 million in the first quarter of 2025. Source
  • Buybacks fell; net debt repaid: Share repurchases were $5.8 million, against $8.0 million a year earlier. Net debt activity was a repayment of $5.9 million, against net borrowing of $18.3 million. Source

Balance sheet and share count

  • Cash balance rose slightly: Cash and cash equivalents were $324.9 million at March 31, 2026, against $322.1 million at December 31, 2025. Source
  • Long-term debt declined: Long-term debt, net of current installments was $201.0 million, against $206.8 million at December 31, 2025; current installments were $3.75 million in both periods. Source
  • Shareholders’ equity slightly lower: Shareholders’ equity was $1,096.5 million, against $1,099.8 million at December 31, 2025. Source
  • Diluted share count lower: Diluted weighted-average shares were 36.3 million, against 36.6 million in the first quarter of 2025. Source

Figures management reported

FigureReported
Semi-Cap revenue Source$191 million, 28% of revenue (Q1 2026); $171 million (Q4 2025); $195 million (Q1 2025)
Industrial revenue Source$133 million, 20% of revenue (Q1 2026); $144 million (Q4 2025); $137 million (Q1 2025)
A&D revenue Source$120 million, 18% of revenue (Q1 2026); $137 million (Q4 2025); $122 million (Q1 2025)
Medical revenue Source$128 million, 19% of revenue (Q1 2026); $144 million (Q4 2025); $104 million (Q1 2025)
AC&C revenue Source$105 million, 15% of revenue (Q1 2026); $108 million (Q4 2025); $74 million (Q1 2025)
Days in inventory Source75 (Q1 2026); 69 (Q4 2025); 89 (Q1 2025)
Gross margin Source10.2% GAAP; 10.3% non-GAAP (Q1 2026)

Earlier plans management reported on

  • Not stated: Management refers to its earlier expectation of mid-single-digit revenue growth for 2026, now replaced by 9-10%. Source
  • Not stated: Management links the quarter to customer-first initiatives it began implementing over two years ago and continues to build on. Source

Other quarters

Summarised with AI from the documents the company filed with the SEC. Every point is checked against the filing before it is shown: management’s own words word for word, figures against the line or table row they come from. A point that fails the check is left out. Source opens the filing at that line.